[96a5a0]: / output / allTrials / identified / NCT02333162_identified.json

Download this file

545 lines (545 with data), 24.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
{
"info": {
"nct_id": "NCT02333162",
"official_title": "A Phase I Study of Intensity Modulated Total Marrow Irradiation (IMTMI) in Addition to Fludarabine/Melphalan Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies",
"inclusion_criteria": "* Patients with the following diseases: acute myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS) undergoing second allogeneic (allo)-stem cell transplant (SCT) using the same donor or different donor for disease relapse; patients with other hematologic malignancies, including acute lymphoblastic leukemia (ALL), will be at the discretion of the investigators\n* Karnofsky performance status of 70 or above\n* Life expectancy is not severely limited by concomitant illness\n* Adequate cardiac and pulmonary function; patients with decreased left ventricular ejection fraction (LVEF) =< 40% or diffusion capacity of carbon monoxide (DLCO) =< 50% of predicted will be evaluated by cardiology or pulmonary prior to enrollment on this protocol\n* Serum creatinine =<1.5 mg/dL or creatinine clearance > 50 ml/min; some patients with minor deviations may be accepted on protocol after discussion with the principal investigator (PI)\n* Serum bilirubin =< 2.0 mg/dl; some patients with minor deviations may be accepted on protocol after discussion with the PI\n* Serum glutamic oxaloacetic transaminase (SGPT) < 5 x upper limit of normal; some patients with minor deviations may be accepted on protocol after discussion with the PI\n* No evidence of chronic active hepatitis or cirrhosis\n* Human immunodeficiency virus (HIV)-negative\n* Patient is not pregnant\n* Patient or guardian able to sign informed consent\n* DONOR: Since these patients already had first allo-SCT; in the majority time, the same matched donor has been used for second allo-SCT; if the patients have multiple donors, alternative matched (8/8 or 10/10) donor could be used for the second allo-SCT; the donor could be matched related donors or matched unrelated donors from registry\n* DONOR: If more than one potential volunteer unrelated donor is considered suitable, further selection of the most suitable donor will be prioritized as follows or will follow our institutional guideline from our stem cell transplant standard operating procedure (SOP):\n\n * Age of donor (18-24 > 25-34 > 35-44 > 45+)\n * Sex of donor (male > female, nulliparous female > parous, multiparous female)\n * Cytomegalovirus (CMV) status, if recipient is CMV seronegative (CMV- > CMV+\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with the following diseases: acute myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS) undergoing second allogeneic (allo)-stem cell transplant (SCT) using the same donor or different donor for disease relapse; patients with other hematologic malignancies, including acute lymphoblastic leukemia (ALL), will be at the discretion of the investigators",
"criterions": [
{
"exact_snippets": "acute myeloid leukemia (AML)",
"criterion": "acute myeloid leukemia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "high risk myelodysplastic syndrome (MDS)",
"criterion": "high risk myelodysplastic syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "undergoing second allogeneic (allo)-stem cell transplant (SCT)",
"criterion": "second allogeneic stem cell transplant",
"requirements": [
{
"requirement_type": "status",
"expected_value": "undergoing"
}
]
},
{
"exact_snippets": "using the same donor or different donor",
"criterion": "donor type for stem cell transplant",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"same donor",
"different donor"
]
}
]
},
{
"exact_snippets": "for disease relapse",
"criterion": "disease relapse",
"requirements": [
{
"requirement_type": "reason for transplant",
"expected_value": true
}
]
},
{
"exact_snippets": "patients with other hematologic malignancies, including acute lymphoblastic leukemia (ALL)",
"criterion": "other hematologic malignancies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "at the discretion of the investigators"
}
]
}
]
},
{
"line": "* Karnofsky performance status of 70 or above",
"criterions": [
{
"exact_snippets": "Karnofsky performance status of 70 or above",
"criterion": "Karnofsky performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Life expectancy is not severely limited by concomitant illness",
"criterions": [
{
"exact_snippets": "Life expectancy is not severely limited by concomitant illness",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "limitation by concomitant illness",
"expected_value": false
}
]
}
]
},
{
"line": "* Adequate cardiac and pulmonary function; patients with decreased left ventricular ejection fraction (LVEF) =< 40% or diffusion capacity of carbon monoxide (DLCO) =< 50% of predicted will be evaluated by cardiology or pulmonary prior to enrollment on this protocol",
"criterions": [
{
"exact_snippets": "Adequate cardiac ... function",
"criterion": "cardiac function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Adequate ... pulmonary function",
"criterion": "pulmonary function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "decreased left ventricular ejection fraction (LVEF) =< 40%",
"criterion": "left ventricular ejection fraction (LVEF)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 40,
"unit": "%"
}
}
]
},
{
"exact_snippets": "diffusion capacity of carbon monoxide (DLCO) =< 50% of predicted",
"criterion": "diffusion capacity of carbon monoxide (DLCO)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 50,
"unit": "% of predicted"
}
}
]
}
]
},
{
"line": "* Serum creatinine =<1.5 mg/dL or creatinine clearance > 50 ml/min; some patients with minor deviations may be accepted on protocol after discussion with the principal investigator (PI)",
"criterions": [
{
"exact_snippets": "Serum creatinine =<1.5 mg/dL",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "creatinine clearance > 50 ml/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "ml/min"
}
}
]
}
]
},
{
"line": "* Serum bilirubin =< 2.0 mg/dl; some patients with minor deviations may be accepted on protocol after discussion with the PI",
"criterions": [
{
"exact_snippets": "Serum bilirubin =< 2.0 mg/dl",
"criterion": "serum bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.0,
"unit": "mg/dl"
}
}
]
}
]
},
{
"line": "* Serum glutamic oxaloacetic transaminase (SGPT) < 5 x upper limit of normal; some patients with minor deviations may be accepted on protocol after discussion with the PI",
"criterions": [
{
"exact_snippets": "Serum glutamic oxaloacetic transaminase (SGPT) < 5 x upper limit of normal",
"criterion": "serum glutamic oxaloacetic transaminase (SGPT)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "x upper limit of normal"
}
}
]
}
]
},
{
"line": "* No evidence of chronic active hepatitis or cirrhosis",
"criterions": [
{
"exact_snippets": "No evidence of chronic active hepatitis",
"criterion": "chronic active hepatitis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No evidence of ... cirrhosis",
"criterion": "cirrhosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Human immunodeficiency virus (HIV)-negative",
"criterions": [
{
"exact_snippets": "Human immunodeficiency virus (HIV)-negative",
"criterion": "HIV status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Patient is not pregnant",
"criterions": [
{
"exact_snippets": "Patient is not pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
},
{
"line": "* Patient or guardian able to sign informed consent",
"criterions": [
{
"exact_snippets": "Patient or guardian able to sign informed consent",
"criterion": "ability to sign informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* DONOR: Since these patients already had first allo-SCT; in the majority time, the same matched donor has been used for second allo-SCT; if the patients have multiple donors, alternative matched (8/8 or 10/10) donor could be used for the second allo-SCT; the donor could be matched related donors or matched unrelated donors from registry",
"criterions": [
{
"exact_snippets": "patients already had first allo-SCT",
"criterion": "first allo-SCT",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "same matched donor has been used for second allo-SCT",
"criterion": "same matched donor for second allo-SCT",
"requirements": [
{
"requirement_type": "usage",
"expected_value": true
}
]
},
{
"exact_snippets": "patients have multiple donors, alternative matched (8/8 or 10/10) donor could be used for the second allo-SCT",
"criterion": "alternative matched donor for second allo-SCT",
"requirements": [
{
"requirement_type": "matching",
"expected_value": [
"8/8",
"10/10"
]
}
]
},
{
"exact_snippets": "donor could be matched related donors or matched unrelated donors from registry",
"criterion": "donor type",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"matched related donors",
"matched unrelated donors from registry"
]
}
]
}
]
},
{
"line": "* DONOR: If more than one potential volunteer unrelated donor is considered suitable, further selection of the most suitable donor will be prioritized as follows or will follow our institutional guideline from our stem cell transplant standard operating procedure (SOP):",
"criterions": [
{
"exact_snippets": "more than one potential volunteer unrelated donor is considered suitable",
"criterion": "volunteer unrelated donor",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": true
}
]
}
]
},
{
"line": "* Age of donor (18-24 > 25-34 > 35-44 > 45+)",
"criterions": [
{
"exact_snippets": "Age of donor (18-24 > 25-34 > 35-44 > 45+)",
"criterion": "age of donor",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<",
"value": 25,
"unit": "years"
}
]
}
},
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 25,
"unit": "years"
},
{
"operator": "<",
"value": 35,
"unit": "years"
}
]
}
},
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 35,
"unit": "years"
},
{
"operator": "<",
"value": 45,
"unit": "years"
}
]
}
},
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 45,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Sex of donor (male > female, nulliparous female > parous, multiparous female)",
"criterions": [
{
"exact_snippets": "Sex of donor (male > female",
"criterion": "sex of donor",
"requirements": [
{
"requirement_type": "preference",
"expected_value": "male > female"
}
]
},
{
"exact_snippets": "nulliparous female > parous, multiparous female",
"criterion": "female donor parity",
"requirements": [
{
"requirement_type": "preference",
"expected_value": "nulliparous > parous, multiparous"
}
]
}
]
},
{
"line": "* Cytomegalovirus (CMV) status, if recipient is CMV seronegative (CMV- > CMV+",
"criterions": [
{
"exact_snippets": "Cytomegalovirus (CMV) status",
"criterion": "Cytomegalovirus (CMV) status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "CMV seronegative"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}